<DOC>
	<DOC>NCT00855127</DOC>
	<brief_summary>The purpose of this study is to find new blood and urine tests that detect acute kidney injury earlier than our current blood tests in patients receiving a liver transplant.</brief_summary>
	<brief_title>New Urine and Blood Markers for Acute Kidney Injury in Liver Transplant Patients</brief_title>
	<detailed_description>Patients with end stage liver disease that receive a liver transplant will be studied to determine if novel serum and urine biomarkers (serum cystatin C, urine interleukin-18 [IL-18] and urine neutrophil gelatinase associated lipocalin [NGAL]) can predict the outcome measures listed above.</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>First time liver transplant recipient Cadaveric or living donor livers Unconscious patients or patients who cannot give consent Pregnant women Prisoners Patients receiving dialysis before or during liver transplant operation Patients receiving simultaneous liverkidney transplants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Biological Markers</keyword>
	<keyword>Renal Replacement Therapy</keyword>
	<keyword>Mortality</keyword>
</DOC>